Fabtech wins ₹63.6 crore contract to build a GMP-compliant pharma plant in West Africa, boosting local medicine production.

AstraZeneca blocked Pharmacor’s generic diabetes drug launch in Australia with a court order, protecting its patent until a full trial.

IGC Pharma gained U.S. and Canadian patent protection for its experimental Alzheimer’s drug IGC-AD1, a major step toward development and potential market launch.

Cellectis, a Paris-based biotech developing gene-edited cancer therapies, received a "Moderate Buy" rating with a $6.33 average 12-month target.

Hearing loss in older adults is linked to cognitive decline through shared brain connectivity issues, suggesting a potential dementia risk and a new biomarker.

Oxybutynin reduced hot flashes in prostate cancer patients on hormone therapy, improving sleep and quality of life with minimal side effects.

Mubadala Bio completes full acquisition of Al Ittihad Drug Store and Global Medical Supply Chain, boosting UAE’s healthcare resilience.

Medanta Noida successfully performed its first three TAVI procedures on high-risk patients, launching a new cardiac care program.

Neflamapimod, targeting neuroinflammation, is being tested in up to 80 ALS patients in a UK trial.

CritiCare Asia Hospitals in Mumbai launched the Smith+Nephew CORI robotic system for precise, minimally invasive joint replacements, enhancing recovery and care access.